{"entity":{"type":"insider","cik":"0001400971","url":"/insider/0001400971","json_url":"/insider/0001400971.json","name":"Campbell Bradley L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":94,"n_filings":85,"first":"2014-08-21","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Campbell Bradley L","source":"filing","n_filings":85,"first_seen":"2014-08-21","last_seen":"2026-03-04"}],"transactions":[{"id":5809669,"accession":"0001193125-26-092114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-092114","line_url":"/filing/0001193125-26-092114#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":14.3484,"price_display":"14.35","price_state":"stated","total_value":322839.0,"total_display":"322,839.00","total_whole":"322,839","shares_owned_after":998680.0,"shares_owned_after_display":"998,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5883724,"accession":"0001193125-26-019838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-019838","line_url":"/filing/0001193125-26-019838#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":14.3091,"price_display":"14.31","price_state":"stated","total_value":1073182.5,"total_display":"1,073,182.50","total_whole":"1,073,183","shares_owned_after":1021180.0,"shares_owned_after_display":"1,021,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider"},{"id":4532298,"accession":"0001193125-25-323151","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-323151","line_url":"/filing/0001193125-25-323151#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77926.0,"shares_display":"77,926","price_per_share":10.8566,"price_display":"10.86","price_state":"stated","total_value":846011.4116,"total_display":"846,011.41","total_whole":"846,011","shares_owned_after":1129782.0,"shares_owned_after_display":"1,129,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-17","scope":"insider"},{"id":4135597,"accession":"0001193125-25-307200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-307200","line_url":"/filing/0001193125-25-307200#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14587.0,"shares_display":"14,587","price_per_share":10.0097,"price_display":"10.01","price_state":"stated","total_value":146011.4939,"total_display":"146,011.49","total_whole":"146,011","shares_owned_after":1137282.0,"shares_owned_after_display":"1,137,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":4532031,"accession":"0001193125-25-301018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-301018","line_url":"/filing/0001193125-25-301018#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14587.0,"shares_display":"14,587","price_per_share":10.0447,"price_display":"10.04","price_state":"stated","total_value":146522.0389,"total_display":"146,522.04","total_whole":"146,522","shares_owned_after":1137282.0,"shares_owned_after_display":"1,137,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4615560,"accession":"0000950170-25-025118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-025118","line_url":"/filing/0000950170-25-025118#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":1150657.0,"shares_owned_after_display":"1,150,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":2125774,"accession":"0000950170-24-132964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-132964","line_url":"/filing/0000950170-24-132964#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.0166,"price_display":"10.02","price_state":"stated","total_value":75124.5,"total_display":"75,124.50","total_whole":"75,125","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-03","scope":"insider"},{"id":3228232,"accession":"0000950170-24-123557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-123557","line_url":"/filing/0000950170-24-123557#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7901.0,"shares_display":"7,901","price_per_share":12.5048,"price_display":"12.50","price_state":"stated","total_value":98800.4248,"total_display":"98,800.42","total_whole":"98,800","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-07","scope":"insider"},{"id":2680626,"accession":"0000950170-24-120981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-120981","line_url":"/filing/0000950170-24-120981#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":11.4613,"price_display":"11.46","price_state":"stated","total_value":85959.75,"total_display":"85,959.75","total_whole":"85,960","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-04","scope":"insider"},{"id":2206468,"accession":"0000950170-24-112905","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-112905","line_url":"/filing/0000950170-24-112905#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.599,"price_display":"10.60","price_state":"stated","total_value":79492.5,"total_display":"79,492.50","total_whole":"79,493","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-04","scope":"insider"},{"id":2638471,"accession":"0000950170-24-104073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-104073","line_url":"/filing/0000950170-24-104073#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":11.7064,"price_display":"11.71","price_state":"stated","total_value":87798.0,"total_display":"87,798.00","total_whole":"87,798","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"},{"id":2205913,"accession":"0000950170-24-091099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-091099","line_url":"/filing/0000950170-24-091099#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.3358,"price_display":"10.34","price_state":"stated","total_value":77518.5,"total_display":"77,518.50","total_whole":"77,519","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider"},{"id":2827167,"accession":"0000950170-24-082476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-082476","line_url":"/filing/0000950170-24-082476#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6100.0,"shares_display":"6,100","price_per_share":10.0048,"price_display":"10.00","price_state":"stated","total_value":61029.28,"total_display":"61,029.28","total_whole":"61,029","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-09","scope":"insider"},{"id":2237433,"accession":"0000950170-24-081542","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-081542","line_url":"/filing/0000950170-24-081542#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":10.0021,"price_display":"10.00","price_state":"stated","total_value":14002.94,"total_display":"14,002.94","total_whole":"14,003","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":3074223,"accession":"0000950170-24-069357","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-069357","line_url":"/filing/0000950170-24-069357#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2176822,"accession":"0000950170-24-053058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-053058","line_url":"/filing/0000950170-24-053058#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.0698,"price_display":"10.07","price_state":"stated","total_value":75523.5,"total_display":"75,523.50","total_whole":"75,524","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-03","scope":"insider"},{"id":2081467,"accession":"0000950170-24-041367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-041367","line_url":"/filing/0000950170-24-041367#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":11.6661,"price_display":"11.67","price_state":"stated","total_value":87495.75,"total_display":"87,495.75","total_whole":"87,496","shares_owned_after":886654.0,"shares_owned_after_display":"886,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3253222,"accession":"0000950170-24-026266","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-026266","line_url":"/filing/0000950170-24-026266#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15833.0,"shares_display":"15,833","price_per_share":13.1382,"price_display":"13.14","price_state":"stated","total_value":208017.1206,"total_display":"208,017.12","total_whole":"208,017","shares_owned_after":871219.0,"shares_owned_after_display":"871,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":2036866,"accession":"0000950170-24-017267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-017267","line_url":"/filing/0000950170-24-017267#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4167.0,"shares_display":"4,167","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":58338.0,"total_display":"58,338.00","total_whole":"58,338","shares_owned_after":871219.0,"shares_owned_after_display":"871,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":2733905,"accession":"0000950170-24-011434","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-011434","line_url":"/filing/0000950170-24-011434#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15833.0,"shares_display":"15,833","price_per_share":12.5597,"price_display":"12.56","price_state":"stated","total_value":198857.7301,"total_display":"198,857.73","total_whole":"198,858","shares_owned_after":875386.0,"shares_owned_after_display":"875,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":2273717,"accession":"0000950170-24-002134","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-002134","line_url":"/filing/0000950170-24-002134","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15833.0,"shares_display":"15,833","price_per_share":14.234800018947768,"price_display":"14.23","price_state":"stated","total_value":225379.5887,"total_display":"225,379.59","total_whole":"225,380","shares_owned_after":947805.0,"shares_owned_after_display":"947,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-02","filed_date":"2024-01-04","scope":"insider","n_lines":2},{"id":7940420,"accession":"0000950170-23-068265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-068265","line_url":"/filing/0000950170-23-068265#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11702.0,"shares_display":"11,702","price_per_share":11.083,"price_display":"11.08","price_state":"stated","total_value":129693.266,"total_display":"129,693.27","total_whole":"129,693","shares_owned_after":792161.0,"shares_owned_after_display":"792,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider"},{"id":7940288,"accession":"0000950170-23-058955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-058955","line_url":"/filing/0000950170-23-058955#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":10.9736,"price_display":"10.97","price_state":"stated","total_value":128391.12,"total_display":"128,391.12","total_whole":"128,391","shares_owned_after":792161.0,"shares_owned_after_display":"792,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":8116966,"accession":"0001209191-23-052109","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-052109","line_url":"/filing/0001209191-23-052109","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":11.23839658119658,"price_display":"11.24","price_state":"stated","total_value":131489.24,"total_display":"131,489.24","total_whole":"131,489","shares_owned_after":792661.0,"shares_owned_after_display":"792,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider","n_lines":2},{"id":8583288,"accession":"0001209191-23-048458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-048458","line_url":"/filing/0001209191-23-048458#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18093.0,"shares_display":"18,093","price_per_share":12.969,"price_display":"12.97","price_state":"stated","total_value":234648.117,"total_display":"234,648.12","total_whole":"234,648","shares_owned_after":792161.0,"shares_owned_after_display":"792,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-06","scope":"insider"},{"id":8221743,"accession":"0001209191-23-044493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-044493","line_url":"/filing/0001209191-23-044493#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":13.3937,"price_display":"13.39","price_state":"stated","total_value":267874.0,"total_display":"267,874.00","total_whole":"267,874","shares_owned_after":798554.0,"shares_owned_after_display":"798,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8439820,"accession":"0001209191-23-042290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042290","line_url":"/filing/0001209191-23-042290#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6800.0,"shares_display":"6,800","price_per_share":12.5134,"price_display":"12.51","price_state":"stated","total_value":85091.12,"total_display":"85,091.12","total_whole":"85,091","shares_owned_after":806854.0,"shares_owned_after_display":"806,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-14","scope":"insider"},{"id":8439813,"accession":"0001209191-23-042290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042290","line_url":"/filing/0001209191-23-042290#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.5057,"price_display":"12.51","price_state":"stated","total_value":18758.55,"total_display":"18,758.55","total_whole":"18,759","shares_owned_after":813654.0,"shares_owned_after_display":"813,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-14","scope":"insider"},{"id":7870807,"accession":"0001209191-23-041656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-041656","line_url":"/filing/0001209191-23-041656#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":12.3091,"price_display":"12.31","price_state":"stated","total_value":144016.47,"total_display":"144,016.47","total_whole":"144,016","shares_owned_after":815154.0,"shares_owned_after_display":"815,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":8545512,"accession":"0001209191-23-035539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035539","line_url":"/filing/0001209191-23-035539#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8300.0,"shares_display":"8,300","price_per_share":12.5032,"price_display":"12.50","price_state":"stated","total_value":103776.56,"total_display":"103,776.56","total_whole":"103,777","shares_owned_after":815154.0,"shares_owned_after_display":"815,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-08","scope":"insider"},{"id":8294675,"accession":"0001209191-23-034637","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-034637","line_url":"/filing/0001209191-23-034637#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":11.3626,"price_display":"11.36","price_state":"stated","total_value":132942.42,"total_display":"132,942.42","total_whole":"132,942","shares_owned_after":823454.0,"shares_owned_after_display":"823,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-05","scope":"insider"},{"id":7839870,"accession":"0001062993-23-010098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-010098","line_url":"/filing/0001062993-23-010098#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":11.8028,"price_display":"11.80","price_state":"stated","total_value":138092.76,"total_display":"138,092.76","total_whole":"138,093","shares_owned_after":823454.0,"shares_owned_after_display":"823,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-03","scope":"insider"},{"id":8250254,"accession":"0001209191-23-023526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023526","line_url":"/filing/0001209191-23-023526#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":11.2143,"price_display":"11.21","price_state":"stated","total_value":131207.31,"total_display":"131,207.31","total_whole":"131,207","shares_owned_after":823454.0,"shares_owned_after_display":"823,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":7994715,"accession":"0001209191-23-015832","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-015832","line_url":"/filing/0001209191-23-015832","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":13.2430592,"price_display":"13.24","price_state":"stated","total_value":264861.184,"total_display":"264,861.18","total_whole":"264,861","shares_owned_after":841373.0,"shares_owned_after_display":"841,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider","n_lines":2},{"id":8391082,"accession":"0001209191-23-007109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-007109","line_url":"/filing/0001209191-23-007109#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.9754,"price_display":"12.98","price_state":"stated","total_value":259508.0,"total_display":"259,508.00","total_whole":"259,508","shares_owned_after":845129.0,"shares_owned_after_display":"845,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":8722246,"accession":"0001209191-23-003082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003082","line_url":"/filing/0001209191-23-003082#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":11.432,"price_display":"11.43","price_state":"stated","total_value":133754.4,"total_display":"133,754.40","total_whole":"133,754","shares_owned_after":805536.0,"shares_owned_after_display":"805,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6614141,"accession":"0001209191-22-059828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-059828","line_url":"/filing/0001209191-22-059828#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5485.0,"shares_display":"5,485","price_per_share":12.2016,"price_display":"12.20","price_state":"stated","total_value":66925.776,"total_display":"66,925.78","total_whole":"66,926","shares_owned_after":689618.0,"shares_owned_after_display":"689,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6574681,"accession":"0001209191-22-055674","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-055674","line_url":"/filing/0001209191-22-055674#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5470.0,"shares_display":"5,470","price_per_share":10.0107,"price_display":"10.01","price_state":"stated","total_value":54758.529,"total_display":"54,758.53","total_whole":"54,759","shares_owned_after":689618.0,"shares_owned_after_display":"689,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6631997,"accession":"0001209191-22-052853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-052853","line_url":"/filing/0001209191-22-052853#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5470.0,"shares_display":"5,470","price_per_share":10.5346,"price_display":"10.53","price_state":"stated","total_value":57624.262,"total_display":"57,624.26","total_whole":"57,624","shares_owned_after":689618.0,"shares_owned_after_display":"689,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6956961,"accession":"0001209191-22-048790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048790","line_url":"/filing/0001209191-22-048790#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5470.0,"shares_display":"5,470","price_per_share":11.2914,"price_display":"11.29","price_state":"stated","total_value":61763.958,"total_display":"61,763.96","total_whole":"61,764","shares_owned_after":689618.0,"shares_owned_after_display":"689,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6631220,"accession":"0001209191-22-044341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-044341","line_url":"/filing/0001209191-22-044341#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5470.0,"shares_display":"5,470","price_per_share":10.0334,"price_display":"10.03","price_state":"stated","total_value":54882.698,"total_display":"54,882.70","total_whole":"54,883","shares_owned_after":689618.0,"shares_owned_after_display":"689,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6517089,"accession":"0001209191-22-041398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-041398","line_url":"/filing/0001209191-22-041398#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5470.0,"shares_display":"5,470","price_per_share":10.7157,"price_display":"10.72","price_state":"stated","total_value":58614.879,"total_display":"58,614.88","total_whole":"58,615","shares_owned_after":689618.0,"shares_owned_after_display":"689,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":6456214,"accession":"0001209191-22-038764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-038764","line_url":"/filing/0001209191-22-038764#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16410.0,"shares_display":"16,410","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":164100.0,"total_display":"164,100.00","total_whole":"164,100","shares_owned_after":689618.0,"shares_owned_after_display":"689,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-22","scope":"insider"},{"id":6250544,"accession":"0001209191-22-020611","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-020611","line_url":"/filing/0001209191-22-020611#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10940.0,"shares_display":"10,940","price_per_share":10.0024,"price_display":"10.00","price_state":"stated","total_value":109426.256,"total_display":"109,426.26","total_whole":"109,426","shares_owned_after":585015.0,"shares_owned_after_display":"585,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider"},{"id":6480372,"accession":"0001209191-22-001198","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-001198","line_url":"/filing/0001209191-22-001198#line-6","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5470.0,"shares_display":"5,470","price_per_share":11.8611,"price_display":"11.86","price_state":"stated","total_value":64880.217,"total_display":"64,880.22","total_whole":"64,880","shares_owned_after":406741.0,"shares_owned_after_display":"406,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider"},{"id":5057392,"accession":"0001209191-21-071071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-071071","line_url":"/filing/0001209191-21-071071#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.6985,"price_display":"11.70","price_state":"stated","total_value":35095.5,"total_display":"35,095.50","total_whole":"35,096","shares_owned_after":457268.0,"shares_owned_after_display":"457,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-23","scope":"insider"},{"id":5501334,"accession":"0001209191-21-067715","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067715","line_url":"/filing/0001209191-21-067715#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400971","owner_name":"Campbell Bradley L","owner_display_name":"Campbell Bradley L","owner_url":"/insider/0001400971","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10515.0,"shares_display":"10,515","price_per_share":11.0039,"price_display":"11.00","price_state":"stated","total_value":115706.0085,"total_display":"115,706.01","total_whole":"115,706","shares_owned_after":457268.0,"shares_owned_after_display":"457,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider"}],"collapsed":true,"next_cursor":"2021-12-01|5501334","ledger_fault":false,"count":{"value":94,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":91,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":94},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS, INC.","url":"/issuer/0001178879","role":"Director, Officer (President and CEO)","n_filings":85,"first_seen":"2014-08-21","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001400971","retrieved_at":"2026-08-24T07:14:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}